BACKGROUND AND OBJECTIVES: Photodynamic therapy (PDT) mediated with Tookad (Pd-bacteriopheophorbide, WST09) was investigated pre-clinically as part of a program to develop an alternative modality for treating prostate cancer. STUDY DESIGN/ MATERIALS AND METHODS: Spontaneous canine prostate cancer and normal canine prostate were used as the animal models. Interstitial PDT was performed by IV infusion of the photosensitizer and irradiating the prostates with a diode laser (763 nm). The prostates were harvested 1-week post-PDT and subjected to histopathologic examinations. The effects of the drug doses and light doses were studied for one- and two-session PDT. Pharmacokinetics were studied using HPLC assay. The feasibility of using perfusing CT scans for assessing PDT lesions was also evaluated. RESULTS: Tookad is a vascular-acting drug and clears rapidly from the circulation. Tookad-PDT-induced lesions, in both normal and cancerous prostates, were characterized by marked hemorrhagic necrosis. CONCLUSIONS: Tookad-PDT is very effective in ablating prostatic tissue through its vascular effects. Copyright 2005 Wiley-Liss, Inc.
BACKGROUND AND OBJECTIVES: Photodynamic therapy (PDT) mediated with Tookad (Pd-bacteriopheophorbide, WST09) was investigated pre-clinically as part of a program to develop an alternative modality for treating prostate cancer. STUDY DESIGN/ MATERIALS AND METHODS: Spontaneous canineprostate cancer and normal canine prostate were used as the animal models. Interstitial PDT was performed by IV infusion of the photosensitizer and irradiating the prostates with a diode laser (763 nm). The prostates were harvested 1-week post-PDT and subjected to histopathologic examinations. The effects of the drug doses and light doses were studied for one- and two-session PDT. Pharmacokinetics were studied using HPLC assay. The feasibility of using perfusing CT scans for assessing PDT lesions was also evaluated. RESULTS: Tookad is a vascular-acting drug and clears rapidly from the circulation. Tookad-PDT-induced lesions, in both normal and cancerous prostates, were characterized by marked hemorrhagic necrosis. CONCLUSIONS: Tookad-PDT is very effective in ablating prostatic tissue through its vascular effects. Copyright 2005 Wiley-Liss, Inc.
Authors: Kenneth C Dole; Qun Chen; Fred W Hetzel; Lawrence R Whalen; Dominique Blanc; Zhen Huang Journal: Photomed Laser Surg Date: 2005-04 Impact factor: 2.796
Authors: R A Hsi; A Kapatkin; J Strandberg; T Zhu; T Vulcan; M Solonenko; C Rodriguez; J Chang; M Saunders; N Mason; S Hahn Journal: Clin Cancer Res Date: 2001-03 Impact factor: 12.531
Authors: J Zilberstein; S Schreiber; M C Bloemers; P Bendel; M Neeman; E Schechtman; F Kohen; A Scherz; Y Salomon Journal: Photochem Photobiol Date: 2001-03 Impact factor: 3.421
Authors: Robert A Weersink; Jason Forbes; Stuart Bisland; John Trachtenberg; Mostafa Elhilali; Pierre H Brún; Brian C Wilson Journal: Photochem Photobiol Date: 2005 Jan-Feb Impact factor: 3.421
Authors: Timothy R Nathan; Douglas E Whitelaw; Stanley C Chang; William R Lees; Paul M Ripley; Heather Payne; Linda Jones; M Constance Parkinson; Mark Emberton; Alison R Gillams; Anthony R Mundy; Stephen G Bown Journal: J Urol Date: 2002-10 Impact factor: 7.450
Authors: Kenneth C Dole; Qun Chen; Fred W Hetzel; Lawrence R Whalen; Dominique Blanc; Zhen Huang Journal: Photomed Laser Surg Date: 2005-04 Impact factor: 2.796
Authors: Zheng Huang; Masoom A Haider; Susan Kraft; Qun Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel Journal: Lasers Surg Med Date: 2006-08 Impact factor: 4.025
Authors: Zheng Huang; Qun Chen; Kenneth C Dole; Al B Barqawi; Yang K Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel Journal: Photochem Photobiol Sci Date: 2007-08-22 Impact factor: 3.982
Authors: Surena F Matin; Peggy T Tinkey; Agatha T Borne; L Clifton Stephens; Avigdor Sherz; David A Swanson Journal: J Urol Date: 2008-05-22 Impact factor: 7.450